Onouchi H

References (1)

Title : SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial - Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125
Author(s) : Inagaki N , Onouchi H , Sano H , Funao N , Kuroda S , Kaku K
Ref : Lancet Diabetes Endocrinol , 2 :125 , 2014
Abstract :
PubMedSearch : Inagaki_2014_Lancet.Diabetes.Endocrinol_2_125
PubMedID: 24622716